Trametinib

Papers on trametinib

27 papers1 new in 30 days

Thursday, October 29

Neuro-oncology

Drug combination limited brain tumor regrowth in mice

In mice carrying childhood brain tumor models, trametinib plus navitoclax reduced regrowth after treatment stopped and improved survival.In mice carrying childhood brain tumor models, trametinib plus navitoclax reduced regrowth after treatment stopped and improved survival.

Trametinib treatment induces senescence and activates the SASP in BT-40 brain tumors in vivo.
Mouse studyInterventions

Tuesday, October 13

Friday, October 2

Wednesday, January 14

Thursday, January 1

Tuesday, December 16

Thursday, July 10

Tuesday, June 24

Thursday, May 29

Saturday, February 8

Wednesday, July 3

Friday, January 19

Tuesday, September 26

Wednesday, June 21

Saturday, September 17

Saturday, September 10

Friday, January 7

Thursday, September 16

Sunday, October 13

Wednesday, October 2

Tuesday, June 26

Tuesday, August 2